These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
129 related items for PubMed ID: 10374398
21. TGF-alpha antisense gene therapy inhibits head and neck squamous cell carcinoma growth in vivo. Endo S, Zeng Q, Burke NA, He Y, Melhem MF, Watkins SF, Lango MN, Drenning SD, Huang L, Rubin Grandis J. Gene Ther; 2000 Nov; 7(22):1906-14. PubMed ID: 11127578 [Abstract] [Full Text] [Related]
23. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Löhr M, Schmidt C, Ringel J, Kluth M, Müller P, Nizze H, Jesnowski R. Cancer Res; 2001 Jan 15; 61(2):550-5. PubMed ID: 11212248 [Abstract] [Full Text] [Related]
25. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F, Lee J, Lu S, Pettaway CA, Dong Z. Clin Cancer Res; 2005 Jun 15; 11(12):4512-20. PubMed ID: 15958637 [Abstract] [Full Text] [Related]
26. Antisense epidermal growth factor receptor (EGFR) transfection down-regulates EGFR expression and suppresses the malignant phenotype of human nasopharyngeal carcinoma CNE-2 cell line. Deng F, Wang Y, Zeng FY, Zou ZP, Bai XC, Lu D, Ke ZY, Luo SQ. Di Yi Jun Yi Da Xue Xue Bao; 2003 Sep 15; 23(9):877-81. PubMed ID: 13129707 [Abstract] [Full Text] [Related]
27. [Reversing malignant phenotypes of liver cancer cell lines with antisense gene to human telomerase reverse transcriptase]. Yang S, Fang D, Liu A, Yang J, Luo Y, Lu R, Liu W. Zhonghua Gan Zang Bing Za Zhi; 2002 Apr 15; 10(2):97-9. PubMed ID: 11983122 [Abstract] [Full Text] [Related]
28. TGF-beta1 acts as a tumor suppressor of human malignant keratinocytes independently of Smad 4 expression and ligand-induced G(1) arrest. Paterson IC, Davies M, Stone A, Huntley S, Smith E, Pring M, Eveson JW, Robinson CM, Parkinson EK, Prime SS. Oncogene; 2002 Feb 28; 21(10):1616-24. PubMed ID: 11896591 [Abstract] [Full Text] [Related]
29. Tumorigenic transformation of NIH 3T3 cells by the autocrine synthesis of transforming growth factor alpha. Ju WD, Velu TJ, Vass WC, Papageorge AG, Lowy DR. New Biol; 1991 Apr 28; 3(4):380-8. PubMed ID: 2065023 [Abstract] [Full Text] [Related]
30. [Experimental study on the effect of VEGF165 antisense RNA on human squamous cell carcinoma of esophagus]. Gu ZP, Wang YJ, Zhou YA, Liu K, Cheng QS, Li JG, Bai XF. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Mar 28; 20(2):199-202. PubMed ID: 15191725 [Abstract] [Full Text] [Related]
31. Reversal of the malignant phenotype of cervical cancer CaSki cells through adeno-associated virus-mediated delivery of HPV16 E7 antisense RNA. Wu S, Meng L, Wang S, Wang W, Xi L, Tian X, Chen G, Wu Y, Zhou J, Xu G, Lu Y, Ma D. Clin Cancer Res; 2006 Apr 01; 12(7 Pt 1):2032-7. PubMed ID: 16609012 [Abstract] [Full Text] [Related]
37. [Transfer and expression of antisense genes of hepatitis B virus (HBV) and their anti-HBV effects]. Ji W, Wang Q, Yu M. Zhonghua Yi Xue Za Zhi; 1997 Jun 01; 77(6):425-9. PubMed ID: 9772506 [Abstract] [Full Text] [Related]
38. [Construction of recombinant vectors expressing antisense RNA to CCR5 and expression in eukaryotic cells]. Xing H, Xu X, Wang Q, Yu M, Gong W, Shao Y. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Mar 01; 16(1):52-4. PubMed ID: 11986747 [Abstract] [Full Text] [Related]
39. Chronic exposure of transforming growth factor beta 1 confers a more aggressive tumor phenotype through downregulation of p21(WAF1/CIP1) in conditionally immortalized pancreatic epithelial cells. Ito D, Fujimoto K, Doi R, Koizumi M, Toyoda E, Mori T, Kami K, Kawaguchi Y, Whitehead R, Imamura M. Surgery; 2004 Aug 01; 136(2):364-74. PubMed ID: 15300203 [Abstract] [Full Text] [Related]
40. [Effects of antisense cyclin D1 expressing vector on the cell growth and apoptosis of pancreatic carcinoma]. Xu Y, Liu T, Gao J. Zhonghua Bing Li Xue Za Zhi; 1998 Oct 01; 27(5):348-51. PubMed ID: 11245009 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]